ConductScience.org, home

Gene · 6359

CCL15: C-C motif chemokine ligand 15

12 sourcesgene-search-2026-11-11-0.2.0

Download JSON
Cite this record

ConductScience Library. CCL15: C-C motif chemokine ligand 15. Genes, record 6359. Release gene-search-2026-11-11-0.2.0, 11 Nov 2026. https://conductscience.org/library/genes/6359

On this page

Gene

Symbol
CCL15
HGNC
Name
C-C motif chemokine ligand 15
HGNC
NCBI Gene ID
6359
NCBI Gene
HGNC ID
HGNC:10613
HGNC
Ensembl
ENSG00000275718
NCBI Gene
Aliases
HCC-2, HMRP-2B, LKN-1, LKN1, Lkn-1, MIP-1 delta, MIP-1D, MIP-1d, MIP-5, MRP-2B, NCC-3, NCC3, SCYA15, SCYL3, SY15
NCBI Gene
Type
protein-coding
NCBI Gene

Proteins1

Reviewed human proteins whose Swiss-Prot entry states the gene.

UniProt entryProteinLengthStructuresGene stated in
Q16663C-C motif chemokine 151133Ensembl, GeneID, HGNC

Source UniProt

Patents65

Patents whose sequence listing contains this protein's exact sequence. A patent can list a sequence without claiming it.

PublicationPublishedSEQ ID NOProteinSource
EP 4650780 A22025-11-1918602Q16663Espacenet
JP 2025147176 A2025-10-062128Q16663Espacenet
JP 2025517970 A2025-06-1218602Q16663Espacenet
JP 2025028160 A2025-02-282128Q16663Espacenet
KR 1020250010750 A2025-01-212128Q16663Espacenet
JP 2024109657 A2024-08-142135Q16663Espacenet
US 11446398 B22022-09-2012736Q16663Espacenet
US 11446398 B22022-09-2012737Q16663Espacenet
US 11446398 B22022-09-2014590Q16663Espacenet
US 11339436 B22022-05-241820Q16663Espacenet

1 to 10 of 65

See all 65 patents

Drugs0

Drugs a ChEMBL mechanism record says act on the gene's protein, through Open Targets.

None in this release.

Trials0

Trials of those drugs. A trial joins the gene only through a drug that acts on it.

None in this release.

NIH grants857

NIH grants whose papers are about the gene, through NIH's grant-paper links.

GrantTitleCCL15 papersNewest fiscal year
UL1TR001863Yale Clinical and Translational Science Award62025
P30CA016672Cancer Center Support Grant52025
P30CA008748Cancer Center Support Grant42025
P30CA047904Cancer Center Support Grant32025
P30CA124435Stanford Cancer Institute32025
P30DK036836Diabetes Research Center32025
P30DK058404Molecular and Cellular Basis for Digestive Diseases32025
P30CA010815Consolidated Basic Cancer Research Program22025
P30CA068485Cancer Center Support Grant22025
P30DK034989Yale Liver Center22025

1 to 10 of 857Source NIH's project files

See all 857 nih grants

Papers1,379

Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.

TitleJournalYearPMIDFound bySource
Association of IL4I1+ M2-like macrophages in tumor microenvironment with poor prognosis in hepatocellular carcinoma: insights from bioinformatics and experimental validation.Front Immunol202642495641PubTator, text miningPubMed
Characterization of the plasma proteomic profile of dual trajectories in cognitive status and physical performance.Geroscience202642301613PubTator, text miningPubMed
Cytokines released by human tumors are independent from cancer histotype.Eur J Cancer202642275854PubTator, text miningPubMed
Characterization of a transmembrane-activating STING agonist using genetically humanized mice.Cell Rep202642228573PubTator, text miningPubMed
Nonlinear Modeling Reveals Novel Associations Between Genetically Predicted Protein Levels and Pancreatic Cancer Risk.Mol Carcinog202642226484PubTator, text miningPubMed
[Effects of immunological and metabolic parameters on the patient's functional outcome in the acute period of ischemic stroke].Zh Nevrol Psikhiatr Im S S Korsakova202641943958PubTator, text miningPubMed
Multiple omics analyses and experiments validation identify PRDX3 as a biomarker of prognosis and antioncogene in kidney clear cell carcinoma.PLoS One202641838687PubTator, text miningPubMed
Proteome-wide Mendelian randomization implicates causal plasma proteins in epilepsy.Clin Neurol Neurosurg202641791135PubTator, text miningPubMed
The role of OSM/OSMRβ axis in shaping the tumor microenvironment favoring MASLD-related HCC immune evasion.Hepatology202641779954PubTator, text miningPubMed
The Role of Rarely Studied Chemokines in Tumor Progression in Multiple Myeloma (MM).Cancers (Basel)202641749925PubTator, text miningPubMed

1 to 10 of 1,379

See all 1,379 papers

Sources 12

  • ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
  • GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
  • HGNCCC0
  • NCBI GenePublic domain (US government)
  • NIH's project files and grant-paper linksPublic domain
  • Open TargetsCC0 1.0
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
  • GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
  • HGNCCC0: https://www.genenames.org/about/license/
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this gene from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/genes/v1/6359

GET https://conductscience.org/api/genes/v1/6359/patents?page=2